awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33628778-A1115F60-BD0B-497E-BD8C-2D56D67106F4
Q33628778-A1115F60-BD0B-497E-BD8C-2D56D67106F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-A1115F60-BD0B-497E-BD8C-2D56D67106F4
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
P2860
Q33628778-A1115F60-BD0B-497E-BD8C-2D56D67106F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-A1115F60-BD0B-497E-BD8C-2D56D67106F4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0575939eba712e7896a547847332ce2e524e905e
P2860
Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.